{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:31:54Z","timestamp":1792989114587,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jad.2024.04.084","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T11:13:40Z","timestamp":1713784420000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Effects of cariprazine on reducing symptoms of irritability, hostility, and agitation in patients with manic or mixed episodes of bipolar I disorder"],"prefix":"10.1016","volume":"358","author":[{"given":"Leslie","family":"Citrome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy-Binh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.04.084_bb0005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4088\/JCP.v63n0910","article-title":"Subsyndromal depression is associated with functional impairment in patients with bipolar disorder","volume":"63","author":"Altshuler","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0010","series-title":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision","author":"APA","year":"2000"},{"key":"10.1016\/j.jad.2024.04.084_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1399-5618.2012.01006.x","article-title":"Is bipolar disorder specifically associated with aggression?","volume":"14","author":"Ballester","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.04.084_bb0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/bdi.12168","article-title":"Prospective longitudinal course of aggression among adults with bipolar disorder","volume":"16","author":"Ballester","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.04.084_bb0025","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2021.1033","article-title":"Novel insights into irritability: the relationship between subjective experience, age and mood","volume":"7","author":"Bell","year":"2021","journal-title":"BJPsych Open"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2024.04.084_bb0030","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jad.2007.02.005","article-title":"Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine","volume":"100","author":"Buckley","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.04.084_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.14m09081","article-title":"Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study","volume":"76","author":"Calabrese","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0040","first-page":"409","article-title":"Asenapine effects on individual Young Mania Rating Scale items in bipolar disorder patients with acute manic or mixed episodes: a pooled analysis","volume":"9","author":"Cazorla","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2024.04.084_bb0045","series-title":"The Diagnosis and Management of Agitation","article-title":"Pharmacologic treatment of agitation","author":"Citrome","year":"2017"},{"key":"10.1016\/j.jad.2024.04.084_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/HRP.0000000000000275","article-title":"Specific anti-hostility effects of atypical antipsychotics in persons with schizophrenia: from clozapine to cariprazine","volume":"29","author":"Citrome","year":"2021","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0055","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1176\/appi.ps.52.11.1510","article-title":"Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia","volume":"52","author":"Citrome","year":"2001","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2024.04.084_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4088\/JCP.15m10192","article-title":"The effect of cariprazine on hostility associated with schizophrenia: post hoc analyses from 3 randomized controlled trials","volume":"77","author":"Citrome","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3371\/1935-1232.10.3.163","article-title":"Guide to the management of clozapine-related tolerability and safety concerns","volume":"10","author":"Citrome","year":"2016","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.jad.2024.04.084_bb0070","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.2147\/NDT.S149376","article-title":"Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder","volume":"13","author":"Citrome","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2024.04.084_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psychres.2005.06.005","article-title":"Findings from the National Comorbidity Survey on the frequency of violent behavior in individuals with psychiatric disorders","volume":"136","author":"Corrigan","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2024.04.084_bb0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bdi.12238","article-title":"The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial","volume":"17","author":"Durgam","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.04.084_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jad.2017.03.032","article-title":"Tolerability of cariprazine in the treatment of acute bipolar I mania: a pooled post hoc analysis of 3 phase II\/III studies","volume":"215","author":"Earley","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.04.084_bb0090","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1080\/14656566.2023.2248893","article-title":"Improving the pharmacotherapeutic treatment of agitation associated with bipolar disorder","volume":"24","author":"Faden","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jad.2024.04.084_bb0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/acps.13558","article-title":"Irritability in bipolar disorder and unipolar disorder measured daily using smartphone-based data: an exploratory post hoc study","volume":"147","author":"Faurholt-Jepsen","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2024.04.084_bb0100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/archgenpsychiatry.2010.97","article-title":"Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review","volume":"67","author":"Fazel","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/JCP.0b013e31816745f7","article-title":"Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials","volume":"28","author":"Frye","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.04.084_bb0110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archpsyc.65.4.386","article-title":"Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse\/recurrence","volume":"65","author":"Judd","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jad.2011.12.046","article-title":"Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes","volume":"138","author":"Judd","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.04.084_bb0120","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archpsyc.63.6.622","article-title":"Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Krakowski","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2008-1077050","article-title":"Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder","volume":"41","author":"Lambert","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0135","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/14740338.2016.1201475","article-title":"An update of safety of clinically used atypical antipsychotics","volume":"15","author":"Orsolini","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2024.04.084_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4088\/JCP.v69n0103","article-title":"Violent behavior and DSM-IV psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions","volume":"69","author":"Pulay","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jad.2014.11.018","article-title":"Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial","volume":"174","author":"Sachs","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.04.084_bb0150","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/1570159X14666161208153644","article-title":"Revisiting antipsychotic-induced akathisia: current issues and prospective challenges","volume":"15","author":"Salem","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2024.04.084_bb0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archpsyc.63.5.490","article-title":"A national study of violent behavior in persons with schizophrenia","volume":"63","author":"Swanson","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0160","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.euroneuro.2015.08.020","article-title":"Effect of cariprazine across the symptoms of mania in bipolar I disorder: analyses of pooled data from phase II\/III trials","volume":"25","author":"Vieta","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2024.04.084_bb0165","first-page":"24","article-title":"Violence in schizophrenia and bipolar disorder","volume":"25","author":"Volavka","year":"2013","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.jad.2024.04.084_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/196281","article-title":"Aggression in psychoses","author":"Volavka","year":"2014","journal-title":"Adv. Psychiatry"},{"key":"10.1016\/j.jad.2024.04.084_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.jcp.0000117424.05703.29","article-title":"Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol","volume":"24","author":"Volavka","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.04.084_bb0180","series-title":"Vraylar [Prescribing Information]","author":"Vraylar","year":"2024"},{"key":"10.1016\/j.jad.2024.04.084_bb0185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724006955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724006955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:45:07Z","timestamp":1723596307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724006955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":37,"alternative-id":["S0165032724006955"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.04.084","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of cariprazine on reducing symptoms of irritability, hostility, and agitation in patients with manic or mixed episodes of bipolar I disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.04.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}